Regulatory T cells impose specific translatome changes in effector CD4 T cells
调节性 T 细胞在效应 CD4 T 细胞中施加特定的翻译组变化
基本信息
- 批准号:9908473
- 负责人:
- 金额:$ 2.89万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-02-03 至 2020-06-30
- 项目状态:已结题
- 来源:
- 关键词:Affinity ChromatographyAntigen-Presenting CellsAutoantigensAutoimmune DiseasesBioinformaticsBiological AssayBiological ProcessBiologyCD4 Positive T LymphocytesCellsCellular StructuresClinicalClustered Regularly Interspaced Short Palindromic RepeatsCritical PathwaysDNADNA Sequence AlterationDataDevelopmentEpitopesEragrostisEventFOXP3 geneGene ExpressionGene Expression RegulationGeneticHomeostasisHumanImmuneImmune ToleranceImmune responseImmunityImmunoprecipitationIn VitroLinkLogicLuciferasesMalignant NeoplasmsMass Spectrum AnalysisMature T-LymphocyteMediatingMessenger RNAModelingMolecularMolecular Biology TechniquesMutagenesisOutputPlayProteinsProteomeRNARegulationRegulatory ElementRegulatory T-LymphocyteReporterResearchRiboTagRibosomal ProteinsRibosomesRoleSignal PathwaySpecificitySyndromeTimeTranscriptTransgenic MiceTranslatingTranslation Process ProteinTranslationsUntranslated Regionsbasebiological systemseffector T cellfollow-upgenetic informationgenome-wideimmune functionin vivomouse modelnovelprogramsrecruitstemtooltranscriptometranscriptomicstranslation factortranslatome
项目摘要
Project Summary/Abstract
Regulatory T cells (Treg) are a distinct subset of immune cells that play a critical role in properly maintaining
immune homeostasis. Indeed, changes in Treg homeostasis or function is highly implicated in a variety of
autoimmune diseases settings as well as in cancer, suggesting clinical importance of understanding Treg
biology. Despite decades of research on Tregs, the molecular basis of how Tregs suppress unwanted immune
responses are unclear. The hurdle mainly comes from ‘too many’ mechanisms proposed as to how Tregs
function. Here, we propose a new paradigm for the function of Tregs with the central hypothesis that Tregs
impose a ‘core’ suppressive program in target effector CD4 T cells (Teff) at the level of ‘translation,’ the
process where proteins are generated from the genetic information encoded in the format of RNA. Although
proteins are the biomolecules that confer most biological function, it is surprising that the steady-state
abundance of mRNA known as the transcriptome is usually the end-point analysis chosen to explain
mechanisms of immune responses. We believe this gap comes from the lack of precise tools to interrogate the
translatome (all the mRNA transcripts that are translated in a given moment) in primary immune cells. We
repurposed the RiboTag genetic tool that introduces an epitope-tag in a core ribosomal protein to study the
translatome of primary immune cells by translating ribosome affinity purification (TRAP). Using this tool, we
propose to follow up on our preliminary observation that indeed Tregs are necessary and sufficient to regulate
the overall protein synthetic output in Teff cells both in vitro and in vivo. In Aim1, we will interrogate the
genome-wide changes in ribosome-bound mRNA transcripts during Treg encounter. We will then characterize
cis-regulatory elements (sequence within the mRNA molecule) in the specific mRNA transcripts using
bioinformatics analysis to understand the mechanism of such specificity. In Aim2, we will explore the
hypothesis that trans-acting protein factors associated with the ribosome (riboproteome) itself is under dynamic
regulation during Treg encounter. Using the same genetic tool that allows direct ribosome immunoprecipitation,
we will interrogate the entire proteome of such bound factors using mass spectrometry analysis. Delineation of
the logic behind how specific mRNAs are chosen in time and space to become functional protein molecules
may revolutionize the way we view gene expression control in immunity.
项目摘要/摘要
调节性T细胞(Treg)是免疫细胞的一个独特亚群,在正确维持
免疫动态平衡。事实上,Treg动态平衡或功能的变化与多种
自身免疫性疾病的环境以及癌症,表明了解Treg的临床重要性
生物学。尽管几十年来对Tregs的研究,Tregs如何抑制不想要的免疫的分子基础
对此的回应尚不清楚。障碍主要来自提出的太多机制,比如特雷格如何
功能。在这里,我们提出了一种新的Tregs功能范式,其中心假设是Tregs
在靶向效应器CD4T细胞(TEFF)的“翻译”水平上强加一个“核心”抑制程序
蛋白质从以RNA格式编码的遗传信息中产生的过程。虽然
蛋白质是赋予大多数生物功能的生物分子,令人惊讶的是,稳态
丰度的mrna被称为转录组,通常是选择终点分析来解释。
免疫反应的机制。我们认为,这一差距来自于缺乏精确的工具来审问
初级免疫细胞中的翻译组(在给定时刻被翻译的所有信使核糖核酸转录本)。我们
改变了RiboTag遗传工具的用途,该工具在核心核糖体蛋白中引入表位标签来研究
翻译核糖体亲和纯化(TRAP)的初级免疫细胞的翻译组。使用这个工具,我们
建议跟进我们的初步观察,即Tregs确实是必要的,并且足以进行监管
在体外和体内TJeff细胞的总蛋白质合成产量。在Aim1中,我们将审问
在Treg相遇期间核糖体结合的mrna转录产物的全基因组变化。然后我们将描述
在特定的mRNA转录本中使用顺式调控元件(mRNA分子内的序列)
通过生物信息学分析来了解这种特异性的机制。在AIM2中,我们将探索
与核糖体(核蛋白质组)本身相关的反式作用蛋白因子处于动态状态的假说
特雷格遭遇期间的规则。使用同样的基因工具,可以直接进行核糖体免疫沉淀,
我们将使用质谱分析来询问这些结合因子的整个蛋白质组。勾画
特定的mRNAs如何在时间和空间上被选择成为具有功能的蛋白质分子背后的逻辑
可能会彻底改变我们看待免疫中基因表达控制的方式。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Lomon So其他文献
Lomon So的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似海外基金
Tri-Signal Artificial Antigen Presenting Cells for Cancer Immunotherapy
用于癌症免疫治疗的三信号人工抗原呈递细胞
- 批准号:
10751133 - 财政年份:2023
- 资助金额:
$ 2.89万 - 项目类别:
Microfluidic Precision Engineered Artificial Antigen Presenting Cells for Cancer Immunotherapy
用于癌症免疫治疗的微流控精密工程人工抗原呈递细胞
- 批准号:
10696138 - 财政年份:2022
- 资助金额:
$ 2.89万 - 项目类别:
The role of microglia as antigen presenting cells in Globoid Cell Leukodystrophy
小胶质细胞作为抗原呈递细胞在球状细胞脑白质营养不良中的作用
- 批准号:
10663066 - 财政年份:2022
- 资助金额:
$ 2.89万 - 项目类别:
The role of microglia as antigen presenting cells in Globoid Cell Leukodystrophy
小胶质细胞作为抗原呈递细胞在球状细胞脑白质营养不良中的作用
- 批准号:
10537159 - 财政年份:2022
- 资助金额:
$ 2.89万 - 项目类别:
Analysis of the function of antigen-presenting cells present in the stroma of colorectal cancer and the intracellular microbiome
结直肠癌基质中抗原呈递细胞和细胞内微生物组的功能分析
- 批准号:
21K08723 - 财政年份:2021
- 资助金额:
$ 2.89万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Class II artificial antigen presenting cells for cancer immunotherapy
用于癌症免疫治疗的 II 类人工抗原呈递细胞
- 批准号:
10156950 - 财政年份:2021
- 资助金额:
$ 2.89万 - 项目类别:
The role of CX3CR1+ antigen presenting cells in T cell selection and central tolerance"
CX3CR1抗原呈递细胞在T细胞选择和中枢耐受中的作用"
- 批准号:
10631854 - 财政年份:2021
- 资助金额:
$ 2.89万 - 项目类别:
Reprogramming Cancer Cells into Antigen Presenting Cells: Cancer Vaccination with mRNA Enabled by Charge-Altering Releasable Transporters
将癌细胞重编程为抗原呈递细胞:通过改变电荷的可释放转运蛋白实现 mRNA 的癌症疫苗接种
- 批准号:
10153927 - 财政年份:2021
- 资助金额:
$ 2.89万 - 项目类别:
Class II artificial antigen presenting cells for cancer immunotherapy
用于癌症免疫治疗的 II 类人工抗原呈递细胞
- 批准号:
10331830 - 财政年份:2021
- 资助金额:
$ 2.89万 - 项目类别:
Analysis on detrimental interplay between pathogenic helper T cells, inflammatory antigen-presenting cells and disease-associated microglia in chronic pathogenesis of multiple sclerosis
多发性硬化症慢性发病机制中致病性辅助 T 细胞、炎症抗原呈递细胞和疾病相关小胶质细胞之间的有害相互作用分析
- 批准号:
20K16294 - 财政年份:2020
- 资助金额:
$ 2.89万 - 项目类别:
Grant-in-Aid for Early-Career Scientists














{{item.name}}会员




